18FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients
暂无分享,去创建一个
D. Groheux | P. Merlet | M. Espié | C. Sotiriou | P. de Cremoux | L. Biard | M. Resche-Rigon | J. Lehmann-Che | L. Teixeira | P. Bertheau | F. Bouhidel | B. Poirot